Liver Failure/Cirrhosis/Portal Hypertension
Article first published online: 1 AUG 2007
Copyright © 2007 American Association for the Study of Liver Diseases
Volume 46, Issue 5, pages 1476–1484, November 2007
How to Cite
Trotter, J. F., Wisniewski, K. A., Terrault, N. A., Everhart, J. E., Kinkhabwala, M., Weinrieb, R. M., Fair, J. H., Fisher, R. A., Koffron, A. J., Saab, S. and Merion, R. M. (2007), Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology, 46: 1476–1484. doi: 10.1002/hep.21845
Presented in part at the World Transplant Congress, Boston, MA, July 2006.
Potential conflict of interest: Dr. Trotter is a consultant for and received grants from Novartis. He is on the speakers' bureau of and received grants from Roche. He is also on the speakers' bureau of Astellas. He also received grants from Cellzdirect, Aventis-Sanofi, and Abbott.
This is publication number 5 of the Adult-to-Adult Living Donor Liver Transplantation Cohort Study.
- Issue published online: 29 OCT 2007
- Article first published online: 1 AUG 2007
- Manuscript Accepted: 31 MAY 2007
- Manuscript Received: 27 MAR 2007
- National Institutes of Health (NIDDK). Grant Numbers: U01-DK62536, U01-DK62444, U01-DK62467, U01-DK62483, U01-DK62484, U01-DK62494, U01-DK62496, U01-DK62498, U01-DK62505, U01-DK62531
- American Society of Transplant Surgeons
- U.S. Department of Health and Human Services, Health Resources and Services Administration
The purpose of donor evaluation for adult-to-adult living donor liver transplantation (LDLT) is to discover medical conditions that could increase the donor postoperative risk of complications and to determine whether the donor can yield a suitable graft for the recipient. We report the outcomes of LDLT donor candidates evaluated in a large multicenter study of LDLT. The records of all donor candidates and their respective recipients between 1998 and 2003 were reviewed as part of the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL). The outcomes of the evaluation were recorded along with demographic data on the donors and recipients. Of the 1011 donor candidates evaluated, 405 (40%) were accepted for donation. The donor characteristics associated with acceptance (P < 0.05) were younger age, lower body mass index, and biological or spousal relationship to the recipient. Recipient characteristics associated with donor acceptance were younger age, lower Model for End-stage Liver Disease score, and shorter time from listing to first donor evaluation. Other predictors of donor acceptance included earlier year of evaluation and transplant center. Conclusion: Both donor and recipient features appear to affect acceptance for LDLT. These findings may aid the donor evaluation process and allow an objective assessment of the likelihood of donor candidate acceptance. (HEPATOLOGY 2007.)